Xiaofeng LI, Dairong ZHANG, Zuxi FENG, Xiangjing XU, Jihong ZHANG, Aiping YU, Li ZHU, Jie XIAO, Junhua DU, Min CHEN

Circular RNA circPRMT5 is upregulated in breast cancer and is required for cell proliferation and migration

Background/aim: To evaluate the role of cyclic protein arginine methyltransferase 5 (circPRMT5) in the occurrence and development of breast cancer (BC). Materials and methods: A total of 90 BC patients who underwent radical mastectomy and 40 age-matched healthy female controls were recruited in the Second People’s Hospital of China Three Gorges University, Yichang Second People’s Hospital from 2017 to 2020. Quantitative reverse transcription polymerase chain reaction (RT-qPCR) was used to detect the expression levels of circPRMT5 in BC tissues, serum, normal breast cell line (MCF-10A), and BC cell line (T47D, MCF-7, BT549, Hs-578T, and MDA-MB-231, MDAMB-468). The associations between circPRMT5 expression level and age, tumor size, degree of differentiation, TNM stage, distant metastasis, estrogen receptor (ER) or progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status were analyzed. BC cell lines with circPRMT5 knockdown or overexpression were subject to CCK-8 cell proliferation assay, and transwell cell invasion/migration assay. Results: CircPRMT5 expression in BC tissue was higher than that in adjacent normal breast tissue. Consistently, the expression level of circPRMT5 was also elevated in serum samples collected from BC patients when compared with healthy controls. And in multiple breast cancer cell lines, circPRMT5 was upregulated as compared to normal breast epithelial MCF-10A cells. CircPRMT5 expression level was correlated with tumor size, TNM stage, lymph node metastasis distant metastasis, but no correlation was observed with ER, PR, HER2 status. Overexpression of circPRMT5 promoted the proliferation, invasion, and migration of MCF7 cells; while the knockdown of circPRMT5 inhibited cell proliferation, invasion, and migration. Conclusion: CircPRMT5 seems to act as an oncogene in the progression of BC. Our data suggest that CircPRMT5 may be used as a biomarker for the diagnosis, prognosis evaluation, and targeted therapy of breast cancer.

PDF

___

1. Bray F, Ferlay J, Soerjomataram I, Siegel R L, Torre L A et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians 2018; 68 (6): 394-424. doi: 10.3322/caac.21492
2. Carioli G, Bertuccio P, Malvezzi M, Rodriguez T, Levi F et al. Cancer mortality predictions for 2019 in Latin America. International Journal of Cancer 2020; 147 (3): 619-632. doi: 10.1002/ijc.32749
3. Li J, Cai H, Sun H, Qu J, Zhao B et al. Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF-kappaB pathway activation. Journal of Ethnopharmacology 2020; 260: 112969. doi: 10.1016/j.jep.2020.112969
4. Li Y, Qin J, Wu J, Dai X, Xu J. High expression of OSR1 as a predictive biomarker for poor prognosis and lymph node metastasis in breast cancer. Breast Cancer Research and Treatment 2020; 182 (1): 35-46. doi: 10.1007/s10549-020- 05671-w
5. Wang Y, Ren S, Wang Z, Wang Z, Zhu N et al. Chemokines in bone-metastatic breast cancer: Therapeutic opportunities. International Immunopharmacology 2020; 87: 106815. doi: 10.1016/j.intimp.2020.106815
6. Peng W, Li T, Pi S, Huang L, Liu Y. Suppression of circular RNA circDHCR24 alleviates aortic smooth muscle cell proliferation and migration by targeting miR-149-5p/MMP9 axis. Biochemical and Biophysical Research Communications 2020; 529 (3): 753-759. doi: 10.1016/j.bbrc.2020.06.067
7. Pan Y, Lou J, Wang H, An N, Chen H et al. CircBA9.3 supports the survival of leukaemic cells by up-regulating c-ABL1 or BCR-ABL1 protein levels. Blood Cells, Molecules and Diseases 2018; 73: 38-44. doi: 10.1016/j.bcmd.2018.09.002
8. Guo X, Dai X, Liu J, Cheng A, Qin C et al. Circular RNA circREPS2 Acts as a Sponge of miR-558 to Suppress Gastric Cancer Progression by Regulating RUNX3/beta-catenin Signaling. Molecular Therapy Nucleic Acids 2020; 21: 577-591. doi: 10.1016/j.omtn.2020.06.026
9. Zhang J, Wang H, Wu K, Zhan F, Zeng H. Dysregulated circRNA_100876 contributes to proliferation and metastasis of colorectal cancer by targeting microRNA-516b (miR516b). Cancer Biology & Therapy 2020; 21 (8): 733-740. doi: 10.1080/15384047.2020.1776075
10. Bian L, Zhi X, Ma L, Zhang J, Chen P et al. Hsa_circRNA_103809 regulated the cell proliferation and migration in colorectal cancer via miR-532-3p / FOXO4 axis. Biochemical and Biophysical Research Communications 2018; 505 (2): 346-352. doi: 10.1016/j.bbrc.2018.09.073
11. Ma X, Liu C, Gao C, Li J, Zhuang J et al. circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer. Journal of Cellular Physiology 2020; 235 (4): 3973-3983. doi: 10.1002/ jcp.29291
12. Li C, Zhou H. Circular RNA hsa_circRNA_102209 promotes the growth and metastasis of colorectal cancer through miR761-mediated Ras and Rab interactor 1 signaling. Cancer Medicine 2020; 9 (18): 6710-6725. doi: 10.1002/cam4.3332
13. Chen X, Chen R X, Wei W S, Li Y H, Feng Z H et al. PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce EpithelialMesenchymal Transition. Clinical Cancer Research: an Official Journal of The American Association for Cancer Research 2018; 24 (24): 6319-6330. doi: 10.1158/1078-0432.CCR-18- 1270
14. Yang B, Du K, Yang C, Xiang L, Xu Y et al. CircPRMT5 circular RNA promotes proliferation of colorectal cancer through sponging miR-377 to induce E2F3 expression. Journal of Cellular and Molecular Medicine 2020; 24 (6): 3431-3437. doi: 10.1111/jcmm.15019
15. Wang Y, Li Y, He H, Wang F. Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498. Gene 2019; 720: 144099. doi: 10.1016/j.gene.2019.144099
16. Ding Z, Guo L, Deng Z, Li P. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis. Annals of Hepatology 2020; 19 (3): 269-279. doi: 10.1016/j.aohep.2020.01.002
17. Sun L, Zheng W, Liu Q, Ge L. Valproic Acid Protects Chondrocytes from LPS-Stimulated Damage via Regulating miR-302d-3p/ITGB4 Axis and Mediating the PI3K-AKT Signaling Pathway. Frontiers in Molecular Biosciences 2021; 8: 633315. doi: 10.3389/fmolb.2021.633315
18. Yu Y, Xiao C, Tan L, Wang Q, Li X et al. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling. British Journal of Cancer 2014; 110 (3): 724-32. doi: 10.1038/ bjc.2013.768
19. Sung H, Devi B, Tang T, Rosenberg P, Anderson W et al. Divergent breast cancer incidence trends by hormone receptor status in the state of Sarawak, Malaysia. International Journal of Cancer 2020; 147 (3): 829-837. doi: 10.1002/ijc.32812
20. Lienhoop T, Smetko M, Green L. Breast cancer in transgender women: A case report. Clinical Imaging 2020; 68: 20-23. doi: 10.1016/j.clinimag.2020.05.006
21. Rojas K, Manasseh D, Rojas M, Mattocks A, Portnow L et al. The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer. Breast Cancer Research and Treatment 2020; 182 (1): 79-83. doi: 10.1007/s10549-020- 05666-7
22. Miyashita H, Cruz C, Malamud S. Risk factors for skeletalrelated events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate. Breast Cancer Research and Treatment 2020; 182 (2): 381-388. doi: 10.1007/ s10549-020-05712-4
23. Cragun D, Weidner A, Tezak A, Clouse K, Pal T. Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers. Breast Cancer Research and Treatment 2020; 182 (2): 421-428. doi: 10.1007/s10549-020-05699-y
24. Xian J, Cheng Y, Qin X, Cao Y, Luo Y et al. Progress in the research of p53 tumour suppressor activity controlled by Numb in triple-negative breast cancer. Journal of Cellular and Molecular Medicine 2020; 24 (13): 7451-7459. doi: 10.1111/ jcmm.15366
25. Brunner A, Suryo Rahmanto A, Johansson H, Franco M, Viiliainen J et al. PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer. Elife 2020; 9. doi: 10.7554/eLife.57894
26. Liu Z, Zhou Y, Liang G, Ling Y, Tan W et al. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death & Disease 2019; 10 (2): 55. doi: 10.1038/s41419-018-1287-1
27. Liang H, Zhang X, Liu B, Jia G, Li W. Circular RNA circABCB10 promotes breast cancer proliferation and progression through sponging miR-1271. American Journal of Cancer Research 2017; 7 (7): 1566-1576.
28. Zhang J, Ke S, Zheng W, Zhu Z, Wu Y. Hsa_circ_0003645 Promotes Breast Cancer Progression by Regulating miR-139- 3p/HMGB1 Axis. Oncotargets and Therapy 2020; 13: 10361- 10372. doi: 10.2147/OTT.S265796
29. Geng Z, Wang W, Chen H, Mao J, Li Z et al. Circ_0001667 promotes breast cancer cell proliferation and survival via Hippo signal pathway by regulating TAZ. Cell & Bioscience 2019; 9: 104. doi: 10.1186/s13578-019-0359-y
30. Du W, Li D, Guo X, Li P, Li X et al. Circ-PRMT5 promotes gastric cancer progression by sponging miR-145 and miR1304 to upregulate MYC. Artificial Cells Nanomedicine and Biotechnology 2019; 47 (1): 4120-4130. doi: 10.1080/21691401.2019.1671857
31. Zhang L, Wang B, Yang J, Yang H. Circ-PRMT5 stimulates migration in esophageal cancer by binding miR-203. European Review for Medical and Pharmacological Sciences 2020; 24 (19): 9965-9972. doi: 10.26355/eurrev_202010_23209
32. Wu D, Jia H, Zhang Z, Li S. Circ-PRMT5 promotes breast cancer by the miR-509-3p/TCF7L2 axis activating the PI3K/ AKT pathway. The Journal of Gene Medicine 2021; 23 (2): e3300. doi: 10.1002/jgm.3300